ZENATECH INC (ZENA) Fundamental Analysis & Valuation

NASDAQ:ZENA • CA98936T2083

Current stock price

2.19 USD
-0.08 (-3.52%)
At close:
2.21 USD
+0.02 (+0.91%)
After Hours:

This ZENA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ZENA Profitability Analysis

1.1 Basic Checks

  • ZENA had negative earnings in the past year.
  • In the past year ZENA has reported a negative cash flow from operations.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

  • ZENA has a worse Return On Assets (-33.63%) than 77.98% of its industry peers.
  • Looking at the Return On Equity, with a value of -64.11%, ZENA is doing worse than 73.29% of the companies in the same industry.
Industry RankSector Rank
ROA -33.63%
ROE -64.11%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ZENA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

4

2. ZENA Health Analysis

2.1 Basic Checks

  • ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ZENA has more shares outstanding
  • The debt/assets ratio for ZENA has been reduced compared to a year ago.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 1.68, we must say that ZENA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ZENA (1.68) is comparable to the rest of the industry.
  • ZENA has a Debt/Equity ratio of 0.78. This is a neutral value indicating ZENA is somewhat dependend on debt financing.
  • ZENA's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. ZENA is outperformed by 71.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACCN/A
WACC10.05%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ZENA has a Current Ratio of 5.42. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ZENA (5.42) is better than 86.28% of its industry peers.
  • ZENA has a Quick Ratio of 5.42. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
  • ZENA's Quick ratio of 5.42 is amongst the best of the industry. ZENA outperforms 86.28% of its industry peers.
Industry RankSector Rank
Current Ratio 5.42
Quick Ratio 5.42
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

4

3. ZENA Growth Analysis

3.1 Past

  • ZENA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1796.50%.
  • Looking at the last year, ZENA shows a very strong growth in Revenue. The Revenue has grown by 320.92%.
  • The Revenue has been decreasing by -4.94% on average over the past years.
EPS 1Y (TTM)-1796.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-743.22%
Revenue 1Y (TTM)320.92%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%1225.1%

3.2 Future

  • ZENA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.55% yearly.
  • ZENA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 376.98% yearly.
EPS Next Y77.18%
EPS Next 2Y-14.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year846.78%
Revenue Next 2Y376.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M
ZENA Yearly EPS VS EstimatesZENA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15 -0.2

0

4. ZENA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZENA. In the last year negative earnings were reported.
  • Also next year ZENA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

  • ZENA's earnings are expected to decrease with -14.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.55%
EPS Next 3YN/A

0

5. ZENA Dividend Analysis

5.1 Amount

  • ZENA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZENA Fundamentals: All Metrics, Ratios and Statistics

ZENATECH INC

NASDAQ:ZENA (3/13/2026, 8:04:29 PM)

After market: 2.21 +0.02 (+0.91%)

2.19

-0.08 (-3.52%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners3.48%
Inst Owner Change20.53%
Ins Owners12.14%
Ins Owner ChangeN/A
Market Cap104.29M
Revenue(TTM)8.40M
Net Income(TTM)-26.42M
Analysts82.86
Price Target7.14 (226.03%)
Short Float %7.21%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.1%
Min Revenue beat(2)12.1%
Max Revenue beat(2)22.09%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.89
P/FCF N/A
P/OCF N/A
P/B 3.44
P/tB 6.41
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.13
BVpS0.64
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.63%
ROE -64.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 710.67%
Cap/Sales 74.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.42
Quick Ratio 5.42
Altman-Z 1.68
F-Score4
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1796.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-743.22%
EPS Next Y77.18%
EPS Next 2Y-14.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)320.92%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%1225.1%
Revenue Next Year846.78%
Revenue Next 2Y376.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8217.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-618.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A

ZENATECH INC / ZENA Fundamental Analysis FAQ

What is the fundamental rating for ZENA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ZENA.


What is the valuation status for ZENA stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENATECH INC (ZENA). This can be considered as Overvalued.


How profitable is ZENATECH INC (ZENA) stock?

ZENATECH INC (ZENA) has a profitability rating of 0 / 10.


Can you provide the financial health for ZENA stock?

The financial health rating of ZENATECH INC (ZENA) is 4 / 10.


What is the expected EPS growth for ZENATECH INC (ZENA) stock?

The Earnings per Share (EPS) of ZENATECH INC (ZENA) is expected to grow by 77.18% in the next year.